Hims & Hers vs. IVIM Health: prices, fine print, and the honest verdict

Tirzepatide pricing

Hims & Hers offers tirzepatide without a published price we could capture. IVIM Health: $278 a month all-in at the 10 mg maintenance basis, dose-scaled from a $208 entry, including the mandatory $75/mo membership.

Semaglutide pricing

Only IVIM Health publishes a semaglutide price here: Semaglutide runs $224 a month all-in at the standing rate ($149 on intro/plan terms). Hims & Hers offers semaglutide without a published price.

Different products, not just different prices

Hims & Hers fulfills the FDA-approved product — reviewed manufacturing, verified identity and sterility, stable legal status — while IVIM Health sells compounded medication: pharmacy-prepared, not FDA-reviewed, and operating under the narrower post-shortage pathways our legal guide tracks. The compounded discount is partly a risk premium; whether it's worth taking depends on the pharmacy behind it and your tolerance for regulatory turbulence.

Transparency

Hims & Hers: No price published (verified 2026-08-05); names its pharmacy — brand fulfillment; compounded program closed to new patients. IVIM Health: Source-verified (verified 2026-08-05); dispensing pharmacy not publicly named. In this market, a named pharmacy and a dated, source-verified price are worth real money — they are what let you check the claim instead of trusting it.

Commitment & cancellation

Hims & Hers: plan recurs; plan recurs until cancelled. IVIM Health: membership mandatory for duration; membership mandatory; $75/mo membership recurs until cancelled.

Two ladders, side by side

The 2.5-to-10 mg climb is the honest stress test: IVIM Health scales $208 → ~$278 by 10 mg (titration lands between $832 and $1,112). A flat ladder makes dose decisions purely clinical; a scaled one attaches an invoice to every escalation — including the post-plateau bump from 10 to 12.5 mg that many patients eventually face. Full framework: the titration cost guide.

The semaglutide board

Only IVIM Health fields a verified semaglutide price here — $224/month all-in (#11 of 19) — while Hims & Hers routes semaglutide demand to brand Wegovy at $349 flat. For a buyer starting on the cheaper molecule with a likely upgrade later, single-molecule programs mean a future re-shop; dual-molecule ones price the whole arc.

The five normalizations, applied to this pair

1 · All-in, not advertised. Hims & Hers bills at manufacturer/insurance rates plus any stated program fee; IVIM Health's ranked figure is $278 ($203 medication + $75 mandatory membership). 2 · Maintenance basis. IVIM Health scales from $208 to $278, and the 10 mg figure is the one ranked. 3 · Terms separated. IVIM Health: standing $278, no prepaid tier — standing rates rank, prepaid effectives are labeled beside them. 4 · Evidence tiered. Hims & Hers: no price published, read 2026-08-05; IVIM Health: source-verified, read 2026-08-05. 5 · Pharmacy weighed. Hims & Hers names brand fulfillment; compounded program closed to new patients; IVIM Health names no pharmacy — in a pharmacy-variance market, disclosure is a scored asset. Run the same five on any roundup you read and most published “cheapest” lists reorder themselves.

Fine print, itemized

Hims & Hers: no membership — the medication figure is the billed figure; plan recurs until cancelled. IVIM Health: a mandatory $75/mo membership folded into our all-in figure; membership mandatory; commitment: membership mandatory for duration. The pattern to police on both sides is the same: memberships that outlive the medication order, renewal-relative cancellation deadlines, and prepaid terms whose refund language matters more than their discount in a year of live litigation. Cancel in writing; screenshot everything.

Transparency, audited

Hims & Hers carries no price published pricing (last read 2026-08-05); pharmacy disclosure is its strong suit — brand fulfillment; compounded program closed to new patients, brand fulfillment. IVIM Health carries source-verified pricing (last read 2026-08-05); its dispensing pharmacy is not publicly named, so the five pharmacy questions (name, 503A/503B status, state licensure, certificate of analysis, formulation) are your pre-purchase homework. Our weighting is unapologetic: in a market of identical molecule names, a dated source-verified price and a named pharmacy are the two claims a buyer can actually check, and they carry 25 of 100 formula points between them — the methodology shows the math, and the pharmacy guide decodes every answer the five questions can return.

Switching between them

Neither program locks the door: a Hims & Hers-to-IVIM Health move is a new intake, a new prescription at the new pharmacy, and a written cancellation at the old shop — typically a one-to-two-week overlap if you time the last fill. What does not move with you: prepaid months, membership balances, and any dose paperwork, so re-state your current rung clearly at the new intake.

Refills, shipping, and the week-to-week reality

Past the pricing page, the operational facts are what a subscriber lives with: Hims & Hers: shipping included; consultation included in plan; async visit model. IVIM Health: shipping included; consultation video visit included in membership; video visit model. Cold-chain shipments run 3–7 days across the market; the recurring failure modes are refill-timing gaps and pharmacy backlogs, so whichever program wins here, order refills a week early and confirm the pharmacy’s current turnaround at intake.

Who should pick which

Pick Hims & Hers if a named pharmacy is non-negotiable for you; only the FDA-approved product will do; you refuse membership fees on principle. Pick IVIM Health if its published terms happen to fit your state, format, or timing. Neither answer is universal — which is the argument for choosing from data with dates on it rather than from whichever ad loaded first.

What verification would take

For Hims & Hers, ranking would require: any published price at all, on a page we can capture and date; the dose structure (flat or scaled, with the 10 mg tier stated); the pharmacy's name, 503A/503B status, and state licensure; commitment and cancellation terms verbatim. We publish the checklist because the gap is fixable — providers that clear it get ranked on the same arithmetic as everyone else, and readers who ask these questions get the answers this page can't yet print.

If neither one fits

Two programs never exhaust the market — the nearest substitutes on the verified board are Mochi Health at $278 (flat, $79 membership included, named pharmacy); Found at $289 (flat, no membership); ShedRx at $289 (dose-scaled, no membership) — or skip straight to the rankings page, where every standard “cheapest / best / no-commitment” question is answered in one sourced sentence.

The verdict

This one is a product decision more than a price decision — cheapest-possible compounded versus FDA-approved brand. Both records, with dates and sources, live in the pricing database.